NCT04655898View on ClinicalTrials.gov

Metabolism and Excretion of [14C]CC-90001 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

December 16, 2020

Primary Completion Date

March 11, 2021

Study Completion Date

March 11, 2021

Conditions

Healthy Volunteer

Interventions

DRUG

[14C]CC-90001

Oral

Trial Locations (1)

53704

Covance Clinical Research Unit Inc, Madison

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Celgene

INDUSTRY